Payments to Acquire Property, Plant, and Equipment of Entrada Therapeutics, Inc. from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Entrada Therapeutics, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2020 to 31 Dec 2025.
  • Entrada Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $1,144,000, a 37% increase year-over-year.
  • Entrada Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $1,041,000, a 67% decline from 2024.
  • Entrada Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $3,158,000, a 44% decline from 2023.
  • Entrada Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $5,614,000, a 94% increase from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Entrada Therapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $1,041,000 -$2,117,000 -67% 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
2024 $3,158,000 -$2,456,000 -44% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
2023 $5,614,000 +$2,727,000 +94% 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2025 2024 FY
2022 $2,887,000 -$1,693,000 -37% 01 Jan 2022 31 Dec 2022 10-K 13 Mar 2024 2023 FY
2021 $4,580,000 +$2,262,000 +98% 01 Jan 2021 31 Dec 2021 10-K 06 Mar 2023 2022 FY
2020 $2,318,000 01 Jan 2020 31 Dec 2020 10-K 15 Mar 2022 2021 FY

Entrada Therapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $1,144,000 +$306,000 +37% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2024 $838,000 -$830,000 -50% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q1 2023 $1,668,000 +$1,074,000 +181% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q1 2022 $594,000 -$314,000 -35% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q1 2021 $908,000 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.